Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2006; 95(01): 202-204
DOI: 10.1055/s-0037-1612586
DOI: 10.1055/s-0037-1612586
Letter to the Editor
Abnormal circulating neutrophil linked matrix metalloproteinase –9 in stable coronary artery disease
Further Information
Publication History
Received
12 October 2005
Accepted
17 November 2005
Publication Date:
15 December 2017 (online)
-
References
- 1 Kai H, Ikeda H, Yasukawa H. et al. Peripheral blood levels of matrix metalloproteases-2 and –9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-72.
- 2 Kalela A, Koivu T, Sisto T. et al. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest 2002; 65: 337-42.
- 3 Lindsey M, Wedin K, Brown M. et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181-7.
- 4 Tao Z, Cavasin M, Yang F. et al. Temporal change in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarcation in mice. Life Sci 2004; 74: 1561-72.
- 5 Lin TC, Li CY, Tsai CS. et al. Neutrophil-mediated secretion and activation of matrix metalloproteinase-9 during cardiac surgery with cardiopulmonary bypass. Anesth Analg 2005; 100: 1554-60.
- 6 Hamsten A, Walldius G, Szamosi A. et al. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986; 73: 1097-110.
- 7 Austen WG, Edwards JE, Frye RL. et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51 (Suppl. 04) 5-40.
- 8 Tayebjee MH, Lip GY, Tan KT. et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 2005; 96: 339-45.
- 9 Pugin J, Widmer M, Kossodo S. et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999; 20: 458-64.
- 10 Delclaux C, Delacourt C, D’Ortho M. et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membranes. Am J Respir Cell Mol Biol 1996; 14: 288-95.
- 11 Price B, Dennison C, Tschesche H. et al. Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome. J Biol Chem 2000; 275: 28308-15.
- 12 Dollery C, Owen C, Sukhowa G. et al. Neutrophil elastase in human atherosclerotic plaque: production by macrophages. Circulation 2003; 107: 2829-36.
- 13 Cundall M, Sun Y, Miranda C. et al. Neutrophilderived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy and Clin Immunol 2003; 112: 1064-71.
- 14 Justicia C, Panes J, Sole S. et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003; 23: 1430-40.
- 15 Romanic AM, Harrison SM, Bao W. et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res 2002; 54: 495-8.
- 16 Owen C, Hu Z, Barrick B. et al. Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. AmJ Respir Cell Mol Biol 2003; 29: 283-94.